The event type is conference participation, specifically the Avendus Spark INDX 2026 Annual Conference.
The event is scheduled for November 16, 2026, at 09:00 AM in Mumbai, conducted in physical mode.
The stated purpose is for Key Managerial Personnel (KMP) of the company to attend the meeting/conference.
The disclosure explicitly states that during the investor meeting, no Unpublished Price Sensitive Information (UPSI) will be disclosed or discussed.
The schedule may undergo change due to exigencies on the part of Investors/Company.
No specific management participants or their designations are provided in the disclosure.
No presentation, earnings deck, transcript, or recording availability is mentioned.
No financial period, forward-looking statements, or strategic themes are referenced in this announcement.
Additional Notes Section
This is a regulatory filing made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The intimation will be available on the company's website (www.medplusindia.com) and on the websites of BSE Limited (www.bseindia.com) and National Stock Exchange of India Limited (www.nseindia.com).
No financial data or performance figures were disclosed in this announcement.
The document is signed by Shrenik Soni, Company Secretary & Compliance Officer (ICSI M. No. F12400).
